Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease.
Clark, James E
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. [electronic resource] - Pharmacology & therapeutics Nov 2007 - 192-206 p. digital
Publication Type: Journal Article; Review
0163-7258
10.1016/j.pharmthera.2007.06.013 doi
Animals
Chronic Disease
Clinical Trials as Topic
Drug Evaluation, Preclinical
Enzyme Inhibitors--pharmacology
Heart Failure--drug therapy
Humans
Myocardial Ischemia--drug therapy
p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. [electronic resource] - Pharmacology & therapeutics Nov 2007 - 192-206 p. digital
Publication Type: Journal Article; Review
0163-7258
10.1016/j.pharmthera.2007.06.013 doi
Animals
Chronic Disease
Clinical Trials as Topic
Drug Evaluation, Preclinical
Enzyme Inhibitors--pharmacology
Heart Failure--drug therapy
Humans
Myocardial Ischemia--drug therapy
p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors